Study on the Influence of Forest Therapy on Healing Experience in Botanical Gardens.
1 other identifier
interventional
42
1 country
1
Brief Summary
The forest healing system is an important topic of alternative therapy in recent years. To study the influence of Forest therapy, the establishment of a pilot experimental model system in which both environmental factors and type of activity are necessary. Therefore, a system based on the Taipei Botanical Garden was introduced by this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 26, 2021
CompletedFirst Submitted
Initial submission to the registry
December 8, 2021
CompletedFirst Posted
Study publicly available on registry
February 8, 2022
CompletedFebruary 8, 2022
January 1, 2022
Same day
December 8, 2021
January 26, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (14)
questionnaire: BPOMS (1st)
Change from baseline Brief Profile of Mood States at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
questionnaire: BPOMS (2nd)
Change from Brief Profile of Mood States at second intervention after 7-day-washout period \& cross-over
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
questionnaire: BAI (1st)
Change from baseline The Beck Anxiety Inventory at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
questionnaire: BAI (2nd)
Change from The Beck Anxiety Inventory at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
questionnaire: BDI-II (1st)
Change from baseline The Beck Depression Inventory II at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
questionnaire: BDI-II (2nd)
Change from The Beck Depression Inventory II at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
questionnaire: BSRS-V (1st)
Change from baseline Brief Symptom Rating Scale V at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
questionnaire: BSRS-V (2nd)
Change from Brief Symptom Rating Scale V at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
physiological indicator: alpha-amylase activity in salivary (1st)
Change from baseline alpha-amylase activity in salivary by using commercial kits (Salimetrics®) at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
physiological indicator: alpha-amylase activity in salivary (2nd)
Change from alpha-amylase activity in salivary by using commercial kits (Salimetrics®) at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
physiological indicator: HRV (Heart Rate Variability) (1st)
Change from baseline HRV by using wrist monitors (ANSWatch®) to measure heart rate, heart rate variability (related to activities of the autonomic nervous system ANS), irregular heartbeats (IRRHB), and 5-minute continuous pulse wave at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
physiological indicator: HRV (Heart Rate Variability) (2nd)
Change from HRV by using wrist monitors (ANSWatch®) to measure heart rate, heart rate variability (related to activities of the autonomic nervous system ANS), irregular heartbeats (IRRHB), and 5-minute continuous pulse wave at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
physiological indicator: blood pressures (systolic and diastolic) (1st)
Change from baseline blood pressures by using wrist monitors (ANSWatch®) to measure blood pressures (systolic and diastolic) at first intervention
baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
physiological indicator: blood pressures (systolic and diastolic) (2nd)
Change from blood pressures by using wrist monitors (ANSWatch®) to measure blood pressures (systolic and diastolic) at second intervention after 7-day-washout
pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Study Arms (2)
activities in the Botanical Garden or Urban
EXPERIMENTALexperiment group is activities in the Botanical Garden, and the control group is activities in urban
Cross-over design
OTHERThe participants are randomized divided into in two groups following by the experiment which is designed by two consecutive times at one week intervals, and the experimental activities and the control activities are staggered.
Interventions
activities in the Taipei Botanical Garden or in Urban
Eligibility Criteria
You may qualify if:
- years old youth (not limited to men and women)
- Those who have the ability and physical strength to walk for more than 120 minutes
- Subjects must voluntarily join the study
You may not qualify if:
- People who smoke or chew betel nuts
- People who have the habit of drinking (drinking more than five standard glasses in any situation)
- Drug addiction (including narcotic drugs and non-narcotics) habitual
- Those who have taken psychosomatic drugs in the past 30 days
- Participating in another clinical trial at the same time, or in the follow-up period of an interventional trial
- Those diagnosed with major injuries
- Women who are currently pregnant or breastfeeding
- Conditions where other subjects cannot cooperate (for example: unable to participate after random assignment, and not signing the subject's consent form)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei city hospital
Taipei, 10845, Taiwan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chung-Hua Hsu
Branch of Chinese Medicine, Taipei City Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
December 8, 2021
First Posted
February 8, 2022
Study Start
April 27, 2021
Primary Completion
April 27, 2021
Study Completion
October 26, 2021
Last Updated
February 8, 2022
Record last verified: 2022-01